| PHIBRO ANIMAL HEALTH CORP (PAHC) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | |
| Balance Sheet Date | 2026-Jun-30 | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | |
| Fiscal Period | Q4-FY2026 | Q3-FY2026 | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | |
| Price to Sales | 1.01x | .84x | 1.49x | 1.03x | 1.17x | .80x | .73x | .77x | .87x | .66x | .52x | .48x | .53x | .57x | .63x | .56x | .56x | .82x | .89x | .94x | 1.02x | 1.40x | 1.24x | .99x | .87x | 1.33x | 1.20x | 1.23x | 1.06x | 1.55x | - | - | 2.09x | - | 1.99x | 1.71x | 1.92x | ||||||||||||
| Price to Book | 3.96x | 3.30x | 6.19x | 4.56x | 5.26x | 3.62x | 3.25x | 3.44x | 3.53x | 2.62x | 1.94x | 1.73x | 1.90x | 1.96x | 2.28x | 2.02x | 2.05x | 2.95x | 3.03x | 3.45x | 3.74x | 4.90x | 4.60x | 3.68x | 3.66x | 5.66x | 5.03x | 4.62x | 4.18x | 5.95x | .01x | .01x | 9.01x | .01x | 8.63x | 7.96x | 8.73x | ||||||||||||
| Price to Earnings | 15.31x | 12.76x | 23.53x | 16.45x | 24.19x | 21.43x | 27.20x | 43.93x | 52.40x | 278.80x | 39.82x | 31.64x | 24.96x | 17.02x | 21.69x | 14.95x | 11.59x | 15.72x | 13.74x | 15.49x | 17.95x | 21.49x | 23.13x | 17.76x | 16.23x | 31.74x | 26.74x | 26.39x | 21.10x | 23.48x | .02x | .02x | 26.50x | .03x | 27.54x | 21.63x | 21.65x | ||||||||||||
| Price to Unlevered FCF | 22.14x | 18.45x | 33.88x | 16.27x | 21.36x | 12.91x | 9.91x | 15.28x | 10.86x | 7.69x | 6.60x | 6.31x | 12.87x | 41.71x | - | - | 31.47x | 24.43x | 24.38x | 18.92x | 17.31x | 24.20x | 20.20x | 13.22x | 10.88x | 17.94x | 13.96x | 17.01x | 20.40x | 27.23x | .03x | .03x | 26.03x | .03x | |||||||||||||||
| Debt to Asset Ratio | .74x | .75x | .76x | .78x | .79x | .80x | .81x | .73x | .74x | .72x | .72x | .72x | .71x | .72x | .72x | .72x | .72x | .71x | .72x | .72x | .72x | .73x | .73x | .76x | .76x | .75x | .72x | .74x | .70x | .70x | .71x | .72x | .72x | .72x | .75x | .75x | .76x | .77x | .81x | .83x | .85x | .87x | .90x | .95x | .94x | .95x | .94x | .95x | |
| Current Ratio | 2.96x | 3.17x | 3.05x | 3.09x | 2.76x | 2.91x | 3.20x | 3.23x | 2.94x | 3.16x | 3.12x | 3.39x | 3.33x | 3.54x | 3.47x | 3.30x | 2.97x | 2.92x | 3.05x | 3.27x | 3.04x | 2.79x | 2.86x | 2.88x | 2.87x | 2.72x | 3.03x | 3.21x | 3.02x | 3.41x | 3.25x | 3.26x | 2.90x | 3.17x | 3.12x | 3.26x | 3.14x | 3.27x | 3.28x | 3.35x | 3.15x | 3.33x | 2.71x | 2.93x | 2.82x | 2.84x | 3.03x | 2.85x | |